Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,446 | 389 | 89.1% |
| Long term medical supply or device loan | $598.20 | 6 | 7.2% |
| Education | $311.38 | 4 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,471 | 56 | $0 (2024) |
| Amgen Inc. | $693.01 | 39 | $0 (2022) |
| Janssen Biotech, Inc. | $612.99 | 33 | $0 (2024) |
| PFIZER INC. | $510.71 | 28 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $417.39 | 21 | $0 (2023) |
| Merck Sharp & Dohme LLC | $387.38 | 19 | $0 (2022) |
| Incyte Corporation | $348.01 | 16 | $0 (2022) |
| Lilly USA, LLC | $333.34 | 16 | $0 (2022) |
| Seagen Inc. | $298.34 | 12 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $199.91 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.51 | 7 | Novartis Pharmaceuticals Corporation ($44.85) |
| 2023 | $732.51 | 24 | Novartis Pharmaceuticals Corporation ($371.07) |
| 2022 | $4,198 | 198 | Novartis Pharmaceuticals Corporation ($717.04) |
| 2021 | $3,297 | 170 | Novartis Pharmaceuticals Corporation ($338.29) |
All Payment Transactions
399 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Oncology | ||||||
| 07/18/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Oncology | ||||||
| 06/13/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
| 03/22/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Oncology | ||||||
| 01/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Immunology | ||||||
| 01/12/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Oncology | ||||||
| 10/06/2023 | Janssen Biotech, Inc. | TECVAYLI, DARZALEX | Food and Beverage | In-kind items and services | $23.46 | General |
| 10/06/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Oncology | ||||||
| 09/15/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Oncology | ||||||
| 09/12/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Oncology | ||||||
| 08/22/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Oncology | ||||||
| 08/04/2023 | G1 Therapeutics, Inc. | COSELA (Drug) | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Oncology | ||||||
| 06/29/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Oncology | ||||||
| 06/01/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug), LUTATHERA | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 05/31/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| 05/31/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Oncology | ||||||
| 05/27/2023 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $34.05 | General |
| Category: TheraSphere_PI | ||||||
| 05/25/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Oncology | ||||||
| 05/18/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological), DARZALEX | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Oncology | ||||||
| 05/03/2023 | PFIZER INC. | BOSULIF (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 04/28/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Oncology | ||||||
| 04/21/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Oncology | ||||||
| 03/15/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA, TECVAYLI | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 54 | 93 | $27,807 | $6,551 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 41 | 79 | $23,621 | $5,565 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $4,186 | $986.16 | 23.6% |
About Liset Ortega
Liset Ortega is a Nurse Practitioner healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2019. The National Provider Identifier (NPI) number assigned to this provider is 1922572973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Liset Ortega has received a total of $8,356 in payments from pharmaceutical and medical device companies, with $127.51 received in 2024. These payments were reported across 399 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($7,446).
As a Medicare-enrolled provider, Ortega has provided services to 54 Medicare beneficiaries, totaling 93 services with total Medicare billing of $6,551. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Miami, FL
- Active Since 01/13/2019
- Last Updated 01/06/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922572973
Products in Payments
- KISQALI (Drug) $689.35
- KEYTRUDA (Biological) $344.16
- DARZALEX (Biological) $318.45
- IBRANCE (Drug) $234.30
- LUMAKRAS (Drug) $201.28
- ZEPZELCA (Drug) $195.81
- OPDIVO (Biological) $181.38
- Nplate (Biological) $179.63
- TAGRISSO (Drug) $164.71
- Lenvima (Drug) $159.77
- INJECTAFER (Drug) $157.33
- myRisk (Device) $153.67
- Kyprolis (Drug) $148.35
- JAKAFI (Drug) $143.88
- REBLOZYL (Biological) $132.15
- LYNPARZA (Drug) $127.31
- VERZENIO (Drug) $120.23
- CYRAMZA (Drug) $118.09
- LUTATHERA (Drug) $108.44
- XTANDI (Drug) $105.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Miami
Haydee Kapin, Dnp, Arnp, Aocn, DNP, ARNP, AOCN
Nurse Practitioner — Payments: $97,304
Terri Pollack, Arnp, ARNP
Nurse Practitioner — Payments: $48,142
Mr. Carlos Larrauri, Arnp, ARNP
Nurse Practitioner — Payments: $22,058
Martha Rostran, A.r.n.p, A.R.N.P
Nurse Practitioner — Payments: $15,209
Ana Harwood, Arnp, ARNP
Nurse Practitioner — Payments: $11,930
Wendy Kays, Arnp, ARNP
Nurse Practitioner — Payments: $10,690